Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1998
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198746A Tricyclic benzazepine vasopressin antagonists
11/11/1998CN1198669A Use of aminoadamantane compound as immunoregulators
11/11/1998CN1040648C Process for preparing 1-deamino-8-D-arginine vasopressin
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834493 Treatment of nervous system disorders
11/10/1998US5834478 Morphinan hydroxamic acid compounds
11/10/1998US5834420 Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation
11/10/1998US5834244 Factor VIIa inhibitors from Kunitz domain proteins
11/10/1998US5834030 Method of increasing the concentration of nitric oxide in human blood
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049161A1 Antithrombotic agents
11/05/1998WO1998049160A1 Antithrombotic agents
11/05/1998WO1998048833A1 Methods for prevention and/or treatment of thrombocytopenia
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048804A1 Antithrombotic agents
11/05/1998WO1998048800A1 Antithrombotic agents
11/05/1998WO1998048798A1 Antithrombotic agents
11/05/1998WO1998048797A1 Antithrombotic agents
11/05/1998WO1998048794A1 Antithrombotic agents
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998033920A3 Tissue factor pathway inhibitor-3
11/05/1998CA2288224A1 Antithrombotic agents
11/05/1998CA2288209A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998CA2288144A1 Antithrombotic agents
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287993A1 Antithrombotic agents
11/05/1998CA2287984A1 Antithrombotic agents
11/05/1998CA2287982A1 Antithrombotic agents
11/05/1998CA2287980A1 Antithrombotic agents
11/05/1998CA2287901A1 Antithrombotic agents
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874844A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/04/1998EP0874638A1 Hemoregulatory compounds
11/04/1998EP0874629A1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998CN1197663A Chinese herbal medicine preparation for glaucoma
11/04/1998CN1040539C 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them
11/03/1998US5831141 Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831030 Antibodies specific for megakaryocyte differentiation factor
11/03/1998US5831026 Process for purifying factor VIII
11/03/1998US5831025 Human activated protein C and process for preparing same
11/03/1998US5830920 Prevention growth of smooth muscle cells
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830872 Esters of D-mannose or of xylitol and their use as medicaments
11/03/1998US5830867 Hemoregulatory peptides for stimulating the myelopoietic system
11/03/1998US5830865 Modified tripeptide stabilizer
11/03/1998US5830849 Vampire bat salivary plasminogen activators
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830468 Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
11/03/1998US5830467 Pharmaceutical preparation containing protein C and a thrombolytically active substance
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998CA1340111C Vectors and compounds for expression of zymogen forms of human protein c
10/1998
10/29/1998WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998WO1998047876A1 Heterocyclic derivatives and their use as antithrombotic agents
10/29/1998WO1998047854A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998WO1998047522A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998WO1998047365A1 Methods for reducing fibrinogen
10/29/1998WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998CA2288027A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998CA2287196A1 Methods for reducing fibrinogen
10/29/1998CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/28/1998EP0873357A2 Antithrombotic agents and methods of use
10/28/1998EP0873356A1 Novel dipeptide amidines as thrombin inhibitors
10/28/1998EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998EP0873130A2 Compositions comprising pvp having an average molecular weight in the range of 3.000 to 14.000 daltons
10/28/1998EP0873117A1 Hemoregulatory compounds
10/28/1998EP0873110A1 Improved hemostatic composition for treating gingival area
10/28/1998EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains
10/28/1998CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/27/1998US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998US5827868 Prostaglandin analogs
10/27/1998US5827849 Cyclic dericatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/27/1998US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998CA1340102C Novel polypeptides with a blood coagulation-inhibiting action, processesfor their preparation and isolation, their use and agents containing them
10/22/1998WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS
10/22/1998WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998WO1998046628A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046627A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046626A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046624A1 A method for stimulating red blood cell production
10/22/1998WO1998046591A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046576A2 Halo-alkoxycarbonyl prodrugs
10/22/1998WO1998046270A2 Polymeric conjugates polyvalently presenting an agent for therapy
10/22/1998WO1998046252A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties